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Summary
 
Resuscitation from hemorrhagic shock induces profound changes in the physiologic processes
of many tissues and activates inflammatory cascades that include the activation of stress tran-
scriptional factors and upregulation of cytokine synthesis. This process is accompanied by acute
organ damage (e.g., lungs and liver). We have previously demonstrated that the inducible nitric
oxide synthase (iNOS) is expressed during hemorrhagic shock. We postulated that nitric oxide
production from iNOS would participate in proinflammatory signaling. Using the iNOS in-
 
hibitor N
 
6
 
-(iminoethyl)-
 
l
 
-lysine or iNOS knockout mice we found that the activation of the
 
transcriptional factors nuclear factor 
 
k
 
B and signal transducer and activator of transcription 3
and increases in IL-6 and G-CSF messenger RNA levels in the lungs and livers measured 4 h
after resuscitation from hemorrhagic shock were iNOS dependent. Furthermore, iNOS inhibi-
tion resulted in a marked reduction of lung and liver injury produced by hemorrhagic shock.
Thus, induced nitric oxide is essential for the upregulation of the inflammatory response in re-
suscitated hemorrhagic shock and participates in end organ damage under these conditions.
 
H
 
emorrhagic shock initiates an inflammatory response
characterized by the upregulation of cytokine expres-
sion (1) and accumulation of neutrophils (2) in a variety of
tissues. These changes are prominent in the lungs and liver
and are likely to contribute to end organ damage and re-
sultant dysfunction after shock. The mechanisms by which
hemorrhage triggers this inflammatory response remain
poorly understood. Heightened adrenergic activity (3) and
systemic release of proinflammatory agents from the gut (4,
5) have been hypothesized to contribute to acute lung in-
jury after hemorrhage. In addition, reactive radicals are
produced after ischemia/reperfusion and resuscitation from
hemorrhagic shock, and have been implicated in a number
of signal transduction pathways (6).
Among the important radicals produced during hemor-
rhagic shock is the bioregulatory molecule nitric oxide
(NO)
 
1
 
 generated catalytically by three enzymes collectively
termed NO synthases. We (7) and others (8) have shown
that the inflammatory or inducible NO synthase (iNOS or
NOS2) is upregulated in both the lungs and liver during
shock. Therefore, this isoform may be capable of catalyzing
the sustained production of NO after the tissue reperfusion
associated with fluid resuscitation. NO can have both di-
rect effects on cell signaling as well as indirect actions medi-
ated by the reaction products formed when NO interacts
with other molecules such as oxygen or superoxide (9). We
hypothesized that enhanced NO production resulting from
iNOS expression would contribute to proinflammatory
signaling in hemorrhagic shock. Hemorrhagic shock exper-
iments were therefore carried out in rats treated with the
iNOS-selective inhibitor 
 
N
 
6
 
-(iminoethyl)-
 
l
 
-lysine (L-NIL;
reference 10) and mice genetically deficient in iNOS. We
report here that iNOS inhibition or deficiency prevents the
upregulation of the inflammatory cytokines IL-6 and gran-
ulocyte colony-stimulating factor (G-CSF), as well as the acti-
vation of key proinflammatory transcriptional factors nuclear
factor (NF)-
 
k
 
B and signal transducer and activator of tran-
scription (Stat)3, and reduced organ damage after hemorrhage.
These data indicate that under conditions of redox stress such
as hemorrhagic shock, induced NO production plays an es-
sential role in the initiation of the inflammatory response.
 
1
 
Abbreviations used in this paper: 
 
ALT, alanine aminotransferase; EMSA,
electrophoretic mobility shift assay; G-CSF, granulocyte colony-stimulating
factor; hSIE, high-affinity serum-inducible element; iNOS, inducible NO
synthase; L-NIL, N
 
6
 
-(iminoethyl)-
 
l
 
-lysine; MAP, mean arterial blood pres-
sure; MPO, myeloperoxidase; mRNA, messenger RNA; NF, nuclear factor;
NO, nitric oxide; p, protein; RT-PCR, reverse transcriptase PCR; SIF, se-
rum-inducible factor; stat, signal transducer and activator of transcription.
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Materials and Methods
 
Hemorrhagic Shock Protocol.
 
This study was approved by the
University of Pittsburgh Institutional Review Board for animal
experimentation and conforms to National Institutes of Health
guidelines for the care and use of laboratory animals. Fasted male
Sprague Dawley rats (270–290 g) were obtained from Charles
River Breeding Laboratory (Cambridge, MA). iNOS-deficient
mice were prepared as previously described (11). We have previously
described in detail our rat model of resuscitated hemorrhagic
shock (12). In brief, animals were anesthetized with methoxyflu-
orane, and then ventilated via endotracheal tubes using a 2.5-ml
tidal volume of room air at 72 breaths/min. The right carotid ar-
tery was cannulated for continuous blood pressure monitoring,
and the left jugular vein was cannulated for blood withdrawal and
fluid administration. After an initial bleed of 2.25 ml/100 g body
weight over 10 min, blood was withdrawn into a heparinized sy-
ringe or returned as needed to maintain a mean arterial blood
pressure (MAP) of 40 mm Hg. At the point in time at which 35%
of the shed blood had been returned (total shed blood volume 7.8
 
6
 
 0.5 ml), the animals were resuscitated to a MAP of 80 mm Hg
by administration of the remaining shed blood plus two times the
shed blood volume in lactated Ringers solution. Total shock time
averaged 157 
 
6
 
 2.3 min. Animals were killed 4 h after the initia-
tion of resuscitation. Control animals underwent cannulation and
anesthesia for an identical period of time as shock animals but
were not bled. One group of animals (
 
n 
 
5 
 
6) received L-NIL (Alexis
Corp., Laufelfingen, Switzerland) at 50 
 
m
 
g/kg/h, whereas the
control group (both sham and shock animals) received saline in-
fusion. L-NIL was dissolved in 1 ml of sterile saline fluid and was
infused at the initiation of resuscitation for a period of 1 h.
The hemorrhagic shock protocol was modified as follows
when performed on mice (11). The animals were anesthetized
with methoxyfluorane. Both femoral arteries were surgically pre-
pared and cannulated, one for continuous blood pressure moni-
toring, the contralateral artery for blood withdrawal or fluid ad-
ministration. Animals were subjected to hemorrhagic shock by
withdrawal of blood with a MAP maintained at 30 mm Hg for 3 h
with continuous monitoring of blood pressure. Animals were re-
suscitated by infusion of the shed blood and intraperitoneal injec-
tion of 1 ml of saline. Animals were killed by exsanguination 4 h
after resuscitation.
 
Hepatic Injury.
 
The release of the hepatocellular enzyme ala-
nine aminotransferase (ALT) into plasma was used as an index of
hepatic injury. Blood samples were collected into heparinized sy-
ringes at the end of observation period. The samples were centri-
fuged and the plasma was frozen at 
 
2
 
70
 
8
 
C for subsequent analy-
sis. ALT release was determined by an automated procedure using
an autoanalyzer (RA 500; Technitron Inc., Tarrytown, NY).
 
Isolation of Organs and Cells.
 
After flushing the carcasses with
cold (4
 
8
 
C) isotonic saline solution via the venous catheter, the
lungs and livers were removed. Samples were immediately frozen
in liquid nitrogen and stored at 
 
2
 
80
 
8
 
C. Total cellular RNA was
extracted from the samples using the method of Chomczyinski et
al. (13). Cohort groups of rats (
 
n
 
 
 
5
 
 5) were used for determina-
tion of lung wet to dry ratio and lung histology. After median
sternotomy and preparation of the trachea, the left pulmonary hi-
lus was isolated and ligated. The left lung was excised and re-
moved for wet to dry ratio. The right lung was fixed by inflating
with formaldehyde solution (4%) for histopathological examina-
tion. Tissue embedding and sectioning were performed using
standard procedures. For histopathological examination, the lungs
of animals were sectioned and stained with hematoxylin and
eosin and for myeloperoxidase (MPO) as described (12). 10 ran-
domly chosen fields of each lung specimen were examined at
 
3
 
400 and blindly scored for number of intensely staining MPO-
positive PMNs as described (12).
 
Reverse Transcriptase PCR Amplification.
 
Total RNA (2.5 
 
m
 
g)
was subjected to first-strand cDNA synthesis using oligo (dT) primer
and Moloney murine leukemia virus (MMLV) reverse transcriptase
(14). Primers were designed to amplify rat G-CSF, IL-6, and
iNOS with the assistance of a PCR primer design program (PCR
Plan; Intelligenetics, Mountain View, CA). The primers used to
amplify rat G-CSF cDNA were as described (12). The sequence
of the IL-6 5
 
9
 
 primer was ACAGCGATGATGCACTGTCAG,
corresponding to nucleotide numbers 297–317 bp of the rat IL-6
cDNA sequence (15). The sequence of the IL-6 3
 
9
 
 primer was
ATGGTCTTGGTCCTTAGCCAC, corresponding to nucle-
otide numbers 633–613 bp. The sequence of the iNOS 5
 
9
 
 primer
was TTGGGTCTTGTTAGCCTAGTC, corresponding to nu-
cleotide numbers 114–134 bp of the rat iNOS cDNA sequence
(16). The sequence of the iNOS 3
 
9
 
 primer was TGTGCAGT-
CCCAGTGAGGAAC, corresponding to nucleotide numbers
375–355 bp. The primers amplified products of 560 bp for G-CSF
(12), 339 bp for IL-6, and 264 bp for iNOS. The identity of the
amplified cDNA fragment obtained from reverse transcriptase
PCR (RT-PCR) reaction with IL-6, G-CSF, and iNOS primers
was confirmed using restriction site analysis as described (12).
PCR conditions were as follows: denaturation at 94
 
8
 
C for 1 min,
annealing at 57
 
8
 
C for 1 min, and polymerization at 72
 
8
 
C for 2
min. PCR reactions were performed in a Perkin Elmer 480 ther-
mocycler (480; Perkin-Elmer Corp., Norwalk, CT) using differ-
ent numbers of cycles to detect a linear range of input RNA. The
optimal cycle number was identified as 30 cycles. Rat peritoneal
macrophages elicited with thyoglycolate and RAW cells (RAW
264.7 macrophage cell line) stimulated in vitro with LPS served as
positive controls for G-CSF, IL-6, and iNOS messenger RNA
(mRNA). The negative control for each set of PCR reactions
contained water instead of DNA template. PCR product (20% of
the reaction volume) of qualitative RT-PCR was electrophorec-
tically separated on a 2% agarose gel and stained with ethidium
bromide.
For semiquantitative RT-PCR (17) 
 
g
 
-
 
32
 
P–endlabeled 5
 
9
 
primer was used. 15 
 
m
 
l of the PCR reaction was separated on a
10% polyacrylamide gel. After gel drying and exposure to a Phos-
phorImager screen (Molecular Dynamics, Sunnyvale, CA), the
relative radioactivity of the bands was determined by volume in-
tegration using laser scanning densitometry. Each gel contained
the same positive control, which permitted normalization of sam-
ples and comparison between gels.
 
Electrophoretic Mobility Shift Assay.
 
Electrophoretic mobility shift
assay (EMSA) was performed using whole-tissue extracts of lung
or liver sections from the experimental groups as described (18).
Binding reactions were performed using 20 
 
m
 
g of extracted pro-
tein and radiolabeled DNA-binding elements. The activation of
NF-
 
k
 
B was determined using the duplex oligonucleotide based
on the NF-
 
k
 
B binding site upstream of the murine iNOS pro-
moter (19). Activation of Stat3 was assessed using the high-affin-
ity serum-inducible element (hSIE) duplex oligonucleotide that
preferentially binds Stat3 and Stat1 (20). EMSA was performed
on a 4% polyacrylamide gel as described (21). The level of tran-
scription factor activation was quantitated using PhosphorImager
analysis of gel shift band intensities. Where indicated, EMSA-
binding reactions were incubated with NF-
 
k
 
B protein (p)50 or
p65 antibodies or antibodies specific for Stat3
 
a
 
 or Stat3
 
b
 
. Antibod-
ies specific for NF-
 
k
 
B p50, NF-
 
k
 
B p65, and Stat3
 
a
 
 were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA) and were gen- 
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erated in goats against the amino acids 350–363 of human NF-
 
k
 
B
p50, in goats against the amino acids 531–550 of human NF-
 
k
 
B p65,
or in rabbits against the COOH-terminal 20 of 21 amino acid
residues of murine Stat3, respectively. Stat3
 
b
 
-specific antibody
was generated at Charles River Pharmaservices (Southbridge,
MA) by immunizing chickens with the COOH-terminal 10
amino acid residues of human Stat3
 
b
 
 conjugated to thyroglobu-
lin. The IgY fraction was purified from egg yolk by the company.
 
Statistics.
 
Unless otherwise indicated, data are presented as
mean 
 
6
 
 SEM. Comparisons of means were performed using
analysis of variance (ANOVA) followed by comparison of indi-
vidual pairs of means using the Scheffe test. Both tests are con-
tained within the StatView program (4.1; Abacus Concepts, Inc.,
Berkeley, CA).
 
Results
 
iNOS Activity Is Required for the Upregulation of IL-6 and
G-CSF mRNA Levels after Hemorrhagic Shock.
 
Hemorrhagic
shock followed by resuscitation results in the upregulation
of proinflammatory cascades in the lung as well as in other
organs (1). The inflammatory response includes the expres-
sion of iNOS during the shock phase after hemorrhage (7,
8). In these experiments, we found that lung iNOS mRNA
levels were increased by 8.7-fold over sham-treated animals
(
 
P
 
 
 
5
 
 0.001) 4 h after resuscitation from hemorrhagic shock
(Fig. 1). To determine if induced NO participates in the
upregulation of cytokine expression after hemorrhagic shock,
rats were subjected to resuscitated hemorrhagic shock
without or with treatment with the iNOS inhibitor L-NIL.
IL-6 and G-CSF mRNA levels have been previously
shown to be consistently elevated in the lungs after resusci-
tation from hemorrhagic shock (18) where they may con-
tribute to leukocyte recruitment and activation (22). The
predominant site for G-CSF mRNA production is the
bronchoepithelial cells lining the luminal side of distal
bronchioles (12). 4 h after resuscitation from hemorrhagic
shock, IL-6 and G-CSF mRNA were increased 3.4- and
2.5-fold, respectively, compared to sham animals (
 
P
 
 
 
5
 
 0.03
and 
 
P
 
 
 
5
 
 0.04, respectively; Fig. 2). This upregulation was
reduced 80 and 53%, respectively (
 
P
 
 
 
5
 
 0.004 and 
 
P
 
 
 
5
 
0.04, respectively) by administration of the iNOS inhibitor
L-NIL. L-NIL alone had minimal effect on IL-6 or G-CSF
mRNA levels in the sham animals (Fig. 2) and did not alter
iNOS mRNA levels in the shocked animals (Fig. 1).
 
Induced NO Upregulates NF-
 
k
 
B and STAT Activation in
Hemorrhagic Shock.
 
Activation of stress transcriptional fac-
tors such as NF-
 
k
 
B and STAT proteins contributes to the
upregulation of cytokines such as IL-6 and G-CSF (23) and
may also be a consequence of exposure of cells and tissues
to these cytokines (24). Therefore, experiments were car-
ried out to measure the activation of these transcriptional
factors with and without iNOS inhibition. NF-
 
k
 
B activa-
tion was determined by EMSA using the duplex oligonu-
cleotide based on a well-characterized NF-
 
k
 
B–binding se-
quence (19). Lungs of animals 4 h after resuscitation from
shock demonstrated a 2.5-fold increase in NF-
 
k
 
B activa-
tion (
 
P
 
 
 
5
 
 0.001) compared to sham controls (Fig. 3 
 
A
 
). Af-
ter L-NIL treatment, levels of NF-
 
k
 
B activation decreased
70% in shocked animals (
 
P
 
 
 
5
 
 0.003). To confirm the iden-
tity of the activated protein–DNA complex, binding assays
were preincubated with a specific antibody against p50 or
p65. The activated NF-
 
k
 
B complex was partially super-
shifted with p50 (Fig. 3 
 
C
 
), and reduced by 50% with anti-
body against p65 (data not shown) indicating that the com-
plex was composed, in part, of both p50 and p65. Binding
of the protein to labeled NF-
 
k
 
B–binding element was
completely inhibited by 25-fold excess of NF-
 
k
 
B duplex
oligonucleotide, but not by up to 100-fold excess of unla-
beled hSIE duplex oligonucleotide (Fig. 3 
 
D
 
).
If iNOS-induced NF-
 
k
 
B activation contributes to the
upregulation of cytokine expression (e.g., G-CSF), then
NF-
 
k
 
B activity capable of binding the NF-
 
k
 
B–containing
elements within the G-CSF promoter should be present
and increased within the lungs of animals subjected to
hemorrhagic shock. The promoter region of G-CSF con-
tains a functional binding site for NF-
 
k
 
B (23) known as
consensus decanucleotide 5
 
9
 
GRGRTTNCYY39 (CK-1).
EMSA using a labeled oligonucleotide based on the CK-1 se-
quence revealed a twofold increase of CK-1–binding activity
(P 5 0.03) over sham control animals in the lungs of ani-
mals subjected to hemorrhagic shock (Fig. 4, A and B).
This binding activity was inhibited completely by 100-fold
excess cold CK-1 duplex oligonucleotide and reduced sub-
stantially by 100-fold excess cold NF-kB duplex oligonu-
Figure 1. Semiquantitative RT-PCR of iNOS mRNA from lungs of
rats subjected to hemorrhagic shock and killed 4 h after resuscitation.
RT-PCR reactions were performed using total RNA (2.5 mg) from the
lungs of shock and sham animals receiving L-NIL (n 5 6, gray bars) or sa-
line (n 5 6, black bars). Reaction products were separated on polyacryl-
amide gels. The gels were dried and exposed to a PhosphorImaging
screen and developed using a PhosphorImager (A). In B, the radioactive
signal in the region corresponding to the predicted amplified fragment of
rat iNOS mRNA was quantitated using scanner laser densitometry and
ImageQuant software and plotted. Values shown represent mean 6 SEM.
The differences between each shock and sham group were significant
(P 5 0.001 for each group).920 Essential Role of Induced Nitric Oxide in Hemorrhagic Shock
Figure 2. Semiquantitative RT-PCR of IL-6 mRNA (A and B) and
G-CSF mRNA (C and D) in lungs of rats subjected to hemorrhagic
shock or sham procedure without (black bars) and with (gray bars) L-NIL
treatment. RT-PCR reactions were performed and analyzed as described
in the legend to Fig. 1. The differences between each shock and sham
group were significant (P <0.03 for each group). The differences be-
tween L-NIL–treated shock and untreated shock groups were significant
(P 5 0.004 for IL-6 and P 5 0.04 for G-CSF).
Figure 3. Activation of NF-kB in the lungs of rats subjected to hemor-
rhagic shock. In A, EMSA was performed using radiolabeled NF-kB–bind-
ing element and 20 mg of protein extracts of shock and sham animals
without or with L-NIL treatment. In B, the radioactive signal was quanti-
tated by PhosphorImager analysis and plotted. The values shown are
mean  6 SEM. Black bars, untreated animals; gray bars, L-NIL–treated ani-
mals. The NF-kB complex in the shock groups was 2.5-fold greater than
in sham controls (P 5 0.001) and was reduced by 70% by L-NIL treat-
ment (P 5 0.003). In C, extracts (20 mg) from untreated shock animals
were incubated with (1) or without (2) a specific antibody against the
p50 portion of the NF-kB heterodimer. In D, extracts (20 mg) of the lung
of a representative shock animal were incubated with the indicated fold
excess of unlabeled duplex oligonucleotide or an unrelated duplex oligo-
nucleotide (hSIE).921 Hierholzer et al.
cleotide. In contrast, binding activity was unaffected by
100-fold excess cold hSIE duplex oligonucleotide (Fig. 4 C).
We have previously shown that hemorrhagic shock re-
sults in activation of STAT proteins in the lungs of rats
(25). G-CSF and IL-6 are among the cytokines known to
activate Stat3 after binding to their specific receptors (24).
Therefore, EMSA for Stat3 was performed to determine
whether the reduced cytokine expression seen with iNOS
inhibition was accompanied by a reduction in Stat3 activa-
tion. The activation of Stat3 was determined in EMSA us-
ing the hSIE, a DNA-binding element that preferentially
binds Stat3 and Stat1. Stat3 and Stat1 proteins bind hSIE as
dimers to form three distinct serum-inducible factor (SIF)
complexes, SIF-A (Stat3 homodimer), SIF-B (Stat1 and
Stat3 heterodimer), and SIF-C (26). SIF-A predominates in
protein extracts of hemorrhagic shock tissues (Fig. 5). After
resuscitation from hemorrhagic shock, Stat3 activation
(SIF-A complex) increased 4.7-fold (P 5 0.002) compared
to sham controls; this increase was almost completely in-
hibited by L-NIL treatment. Although G-CSF and IL-6
both induce activation of Stat3, each activates a distinct iso-
form of Stat3; IL-6 activates Stat3a (27), whereas extracts
of G-CSF–stimulated PMN contained only Stat3g, a short
isoform of Stat3 derived from proteolytic cleavage of
Stat3a (28, and Tweardy, D.J., unpublished data). A third
isoform of Stat3, known as Stat3b (p83), is derived from al-
ternative RNA splicing (21). Animals subjected to hemor-
rhagic shock demonstrated activation of all three isoforms
as determined by supershift assays using antibodies specific
for Stat3a and Stat3b (Fig. 5 B). Incubation with the
Stat3a- or Stat3b-specific antibody resulted in supershift of
Stat3a and Stat3b, respectively; however, incubation with
both antibodies did not completely supershift the SIF-A
Figure 4. Increased CK-1–binding activity (BA) of lung extracts of
shock animals. In A, EMSA was performed using 20 mg of extract of lung
from animals subjected to hemorrhagic shock, sham animals, normal con-
trol animals, and duplex oligonucleotide. CK-1 is based on an element
within the promoter region of the G-CSF gene that contains a functional
NF-kB binding site. In B, CK-1 BA was quantitated by PhosphorImager
analysis and the mean and 6 SEM plotted. CK-1 BA in shock animals
was increased twofold over sham animals (P 5 0.03). In C, EMSA was
performed using extracts of a representative shock lung and CK-1 duplex
oligonucleotide in the presence of the indicated unlabeled duplex oligo-
nucleotides at the indicated fold excess. The position of the CK-1–bind-
ing activity (CK-1, BA) is indicated on the left.
Figure 5. Increased Stat3 activation in extracts of lungs of animals sub-
jected to hemorrhagic shock and resuscitation. In A, EMSA was per-
formed using the hSIE duplex oligonucleotide and 20 mg of extracts from
shock animals (hemorrhagic shock, HS) or sham animals treated or un-
treated with L-NIL. The position of the SIF-A, -B, and -C complex are
indicated. In B, the SIF-A band was quantitated by PhosphorImager anal-
ysis and the mean 6 SEM for each group plotted. The mean of the SIF-A
complexes in the shock group was 4.7-fold greater than in sham controls
(P 5 0.002) and was significantly reduced by L-NIL treatment (P 5
0.04). In C, extracts of a representative lung were incubated with anti-
bodies specific for Stat3a, Stat3b, or with both antibodies. The position
of the SIF-A, -B, and -C complexes and the residual SIF-A complex after
supershift of Stat3a and Stat3b (Stat3g) are indicated.922 Essential Role of Induced Nitric Oxide in Hemorrhagic Shock
complex. The nonsupershifted portion demonstrated mo-
bility similar to Stat3g. DNA-affinity purification of whole-
tissue extracts of hemorrhagic shock lungs followed by im-
munoblotting with Stat3-specific monoclonal antibody that
recognizes all Stat3 isoforms confirmed the activation of all
three Stat3 isoforms including Stat3g (data not shown). Af-
ter L-NIL treatment, a marked reduction in the activation
of all three Stat3 isoforms was observed (Fig. 5 A). Reduc-
tion in the Stat3g isoform was consistent with reduced
PMN infiltration into the lung as seen in histological assess-
ment (see below). These data provide indirect evidence for
reduced cytokine action within the tissue that is subjected
to downregulation of cytokine production by the inhibi-
tion of iNOS.
iNOS Inhibition Reduces Lung Injury in Hemorrhagic Shock.
One consequence of the upregulation of inflammatory cas-
Figure 6. Lung injury is attenu-
ated after L-NIL treatment of
shock animals. The lungs of
sham animals, untreated shock
animals, and L-NIL–treated
shock animals obtained 4 h after
resuscitation were inflated and
fixed in formaldehyde, and then
sectioned, and examined at
3400. Lung injury was assessed
histologically using sections
stained by hematoxylin and eosin
(top), and PMN accumulation
was assessed by staining for MPO
(bottom). In B, 10 random fields of each MPO-stained lung specimen were blindly scored for number of intensely MPO-positive PMNs. The scores were
pooled for untreated animals (black bars) and L-NIL-treated animals (gray bars) and the means 6 SEM were plotted. The increase in shock animals com-
pared to sham animals was significant (P 5 0.001); the decrease in shock animals treated with L-NIL compared to untreated animals was significant (P 5
0.02). In C, the wet to dry ratio of each sham and shock animal was corrected by subtracting the mean value for normal animals (4.15 6 0.3, n 5 6) and
the increased mean 6 SEM of animals untreated (black bars) or L-NIL–treated (gray bars) was plotted. The increase in wet to dry ratio in shock animals
compared to sham animals was significant (P 5 0.01). The decrease in wet to dry ratio in L-NIL–treated shock animals compared to untreated shock an-
imals was significant (P 5 0.03).923 Hierholzer et al.
cades after hemorrhagic shock is organ damage manifested
by accumulation of PMNs and interstitial fluid. In this
study we examined whether or not the reduction in cytokine
production and proinflammatory signaling in L-NIL–treated
rats was associated with a decrease in lung injury. Lung in-
jury was assessed by histology as well as wet to dry ratio.
After hemorrhagic shock, lung PMN infiltration increased
by 4.7-fold (P 5 0.001) at 4 h resuscitation, as determined
by MPO staining (Fig. 6). L-NIL treatment resulted in a
44% decrease in PMN accumulation (P 5 0.02). The wet
to dry ratio increased by 24% in untreated shocked animals
compared to sham animals (P 5 0.01, Fig. 6 C). This was
accompanied by the histologic markers of tissue fluid leak,
including widened interstitium due to interstitial edema
(Fig. 6 A). The increase in lung wet to dry ratio comparing
shock and sham animals was inhibited by L-NIL treatment
by 33% (P 5 0.03), which was accompanied by an obvious
reduction in the histologic appearance of interstitial fluid
accumulation (Fig. 6 A).
iNOS Inhibition Prevents Cytokine Expression and Transcrip-
tional Factor Activation in the Liver. Hemorrhagic shock with
resuscitation is commonly viewed as a whole body isch-
emia/reperfusion insult. Although the degree of ischemia
may be variable in the pulmonary circulation, the splanch-
nic viscera experience a marked reduction in blood flow
during circulatory shock and hypovolemia. To examine an
organ subjected to severe ischemia/reperfusion during hem-
orrhagic shock and resuscitation as well as to establish whether
similar proinflammatory effects of L-NIL treatment oc-
curred outside of the lungs, we examined cytokine expres-
sion and transcriptional factor upregulation in the liver.
Animals subjected to hemorrhagic shock and resuscitation
demonstrated a 6.7-fold increase in IL-6 mRNA levels
(P 5 0.002), and a 3.3-fold increase in G-CSF mRNA lev-
els (P 5 0.003) compared to sham animals (Fig. 7). By con-
trast, L-NIL treatment reduced mRNA levels for IL-6 by
56% (P 5 0.01) and for G-CSF by 51% (P 5 0.02) when
compared to untreated hemorrhaged animals. In shocked
animals, the activation of NF-kB and the activation of
Stat3 homodimer (SIF-A) were increased by 2.8- and 4.3-
fold, respectively, in the liver compared to sham animals
(P 5 0.002 and P 5 0.001, respectively; Fig. 8). After
L-NIL treatment, shocked animals demonstrated a marked
reduction in the activation of both stress transcriptional fac-
tors. NF-kB activation was inhibited by 83% (P 5 0.001)
compared to the untreated shock group, whereas activated
Stat3 was reduced by 58% (P 5 0.001). In addition, we
found that liver damage measured by plasma transaminase
levels was significantly reduced in the NIL-treated rats sub-
jected to hemorrhagic shock (J. Menezes, unpublished ob-
servations). Thus, the response of the liver after hemor-
rhagic shock was comparable to that observed in the lung
and was mediated, in part, by induced NO.
Studies Using iNOS Knockout Mice. Although L-NIL is
a selective iNOS inhibitor, it may have some activity on
other NO synthase isoforms (10) or may have other non-
specific effects. Therefore, to provide confirmation that the
observed effects with L-NIL were due to the inhibition of
Figure 7. Semiquantitative RT-PCR of IL-6 mRNA (A and B) and
G-CSF mRNA (C and D) in livers of rats subjected to hemorrhagic
shock or sham procedure without (black bars) and with (gray bars) L-NIL
treatment. RT-PCR reactions were performed and analyzed as described
in the legend to Fig. 1. The differences between each shock and sham
group were significant (P ,0.01 for each group). IL-6 mRNA levels
were decreased by 56% (P 5 0.01), whereas G-CSF mRNA levels de-
creased by 51% (P 5 0.02) in L-NIL–treated shock animals compared to
untreated shock animals.924 Essential Role of Induced Nitric Oxide in Hemorrhagic Shock
the inducible form of NO synthase, we measured the acti-
vation of NF-kB and Stat3 in the lungs and the liver of
iNOS-deficient and wild-type mice 4 h after hemorrhagic
shock. Similar to the results seen in rats, hemorrhagic shock
followed by resuscitation resulted in NF-kB and Stat3 acti-
vation in the lung (Fig. 9) and liver (Fig. 10) compared to
sham-treated mice. In mice lacking the iNOS gene, the ac-
tivation of NF-kB and Stat3 was reduced by 44% (P 5 0.01)
and 51% (P 5 0.04), respectively, in the lung, and by 62%
(P 5 0.02) and 54% (P 5 0.01), respectively, in the liver,
when compared to wild-type animals. Similar to L-NIL
treatment in rats, mice lacking the iNOS gene exhibited
less liver damage when subjected to resuscitated shock than
wild-type animals (Fig. 11).
Discussion
This study was undertaken to determine to what degree
induced NO contributes to the inflammatory response and
subsequent end organ damage after resuscitation from hem-
orrhagic shock. We have extended previous studies (7, 8)
by showing that iNOS is not only upregulated during
shock, but that it remains elevated after resuscitation. Using
either the iNOS inhibitor L-NIL or iNOS knockout mice,
we demonstrate that iNOS contributes to the induced ex-
pression of the cytokines IL-6 and G-CSF in the lung and
liver after hemorrhagic shock. The iNOS-dependent in-
crease in IL-6 and G-CSF mRNA levels is associated with
an iNOS-dependent increase in NF-kB and Stat3 activa-
tion in these tissues. An association between the upregula-
tion of these proinflammatory events by NO and organ in-
jury is shown by our experiments, demonstrating reduced
PMN accumulation and edema formation in the lungs, and
reduced plasma levels of liver enzymes with iNOS suppres-
sion. These data provide compelling evidence, not only
that iNOS is in part responsible for lung and liver damage
after hemorrhage and resuscitation, but that the induction
of NO synthesis is a key event in the subsequent activation
of inflammatory cascades after resuscitation.
During hemorrhagic shock, iNOS is upregulated in sev-
eral sites including the lung and liver (8). The mechanism
of upregulation is unclear, but could include hypoxia (6) or
the action of cytokines. We have shown that iNOS expres-
sion increases in parallel with the duration of shock (7).
Others have suggested that iNOS contributes to the initial
vascular decompensation in hemorrhagic shock (8, 29) and
we have suggested that the iNOS expression pattern is con-
Figure 8. Activation of NF-kB and Stat3 in the liver of rats subjected to
hemorrhagic shock. In A, EMSA was performed using radiolabeled
NF-kB duplex oligonucleotide (A) or radiolabeled hSIE (C) and 20 mg of
protein extracts of shock and sham animals without or with L-NIL treat-
ment. The positions of NF-kB and the SIF-A, -B, and -C complexes are
indicated on the left. In B and D, the radioactive signal was quantitated by
PhosphorImager analysis and the mean 6 SEM plotted. The values shown
are mean 6 SEM. Black bars, untreated animals (n 5 5); gray bars, L-NIL–
treated animals. In shocked animals, the activation of NF-kB and the acti-
vation of Stat3 were increased significantly compared to sham animals
(P 5 0.002 and P 5 0.001, respectively). after L-NIL treatment NF-kB
activation was reduced 83% (P 5 0.001) and activation of Stat3 was re-
duced 58% (P 5 0.001) in shocked animals compared to untreated shock
animals.925 Hierholzer et al.
sistent with the possibility that iNOS may contribute to the
progressive vascular dysfunction seen with sustained shock
(7). The current data support the idea that NO can increase
cytokine expression through the activation of NF-kB, and
that the activation of Stat3 may be the result of local cyto-
kine expression (24, 30). Indirect evidence for this possibil-
ity is provided by the demonstration that NF-kB binding
specific for the CK-1 element in the G-CSF promoter is
present in hemorrhagic shock tissues. Furthermore, activa-
tion of Stat3 isoforms characteristic of IL-6 and G-CSF
stimulation were identified as part of the activated Stat3
complex. Full resuscitation of the animals requires 20 min.
However, as early as 1 h after the initiation of resuscitation,
we found that the levels of IL-6 and G-CSF mRNA, as
well as NF-kB and Stat3 activation in lungs and livers,
were elevated to levels similar to those observed at 4 h (data
not shown). Thus, it is likely that the NO-mediated signal-
ing events that are initiated in early phases of resuscitation
result in the rapid activation of downstream cascades. Al-
though NO produced by the constitutive NO synthase has
well-documented signaling functions in many systems, our
novel observations provide strong evidence that induced
NO also participates in lung cell signaling events in inflam-
mation. That iNOS regulation of inflammatory gene ex-
pression is perhaps a more generalized phenomenon is sup-
ported by a recent observation that the upregulation of
interferon g and the response to IL-12 after Leishmania major
infection is iNOS dependent (31, and Bogdan, C., personal
communication). Our results, however, do not exclude the
possibility that the observed differences in both the L-NIL–
treated rats and the iNOS knockout mice are due to some
degree on changes in organ perfusion and oxygen delivery
resulting from reduced NO availability.
NO is known to act as a signaling molecule in other cir-
cumstances either by activation of soluble guanylyl cyclase
resulting in elevated cyclic guanosine 39,59 monophosphate
(cGMP; reference 32) or through S-nitrosylation of pro-
teins containing cysteine residues (33). Significant differ-
ences in cytokine mRNA levels (14, 18) and transcriptional
factor activation (25) between the shock and sham groups
was seen only after resuscitation, indicating that reperfusion
was required. This suggests that redox-sensitive mecha-
nisms were responsible for the NO-mediated signaling.
Figure 9. NF-kB and Stat3 activation in the lungs of wild-type (WT)
and iNOS knockout (KO) mice subjected to hemorrhagic shock. EMSA
was performed using radiolabeled NF-kB duplex oligonucleotide (A) or
radiolabeled hSIE (C) and 20 mg of protein extracts of shock and sham
wild-type or knockout mice. The position of NF-kB and the SIF-A, -B,
and -C complexes are indicated on the left. In B and D, the radioactive
signal was quantitated by PhosphorImager analysis and plotted. The values
shown are mean 6 SEM. Black bars, wild-type mice (n 5 5); gray bars,
knockout mice (n 5 5). In shocked wild-type mice, the activation of
NF-kB and the activation of Stat3 homodimer (SIFA) were increased sig-
nificantly compared to sham wild-type mice (P <0.01). In shocked
knockout mice, NF-kB activation was reduced 44% (P 5 0.01) and acti-
vation of Stat3 homodimer (SIF-A) was reduced 51% (P 5 0.04) com-
pared to shocked wild-type mice.926 Essential Role of Induced Nitric Oxide in Hemorrhagic Shock
Lander et al. (6, 34) have shown that NO activates p21ras
through S-nitrosylation and that this occurs more effi-
ciently in human T cells subjected to oxidative stress.
Downstream events include p38 kinase activation (35) and
NF-kB activation. In hemorrhagic shock, tissues are sub-
jected to redox stress by hypoxia and oxygen radical pro-
duction making S-nitrosylation of p21ras a reasonable can-
didate mechanism. A recent report demonstrates a role for
increased phosphatidic acid in the signaling cascade in-
volved in macrophage cytokine synthesis after hemorrhagic
shock in mice (36). A relationship between phosphatidic
acid and NO is not apparent at this time.
We have previously shown that nonspecific NO syn-
thase inhibition increases organ injury in hemorrhagic
shock (37), whereas here we show that the suppression of
inflammation associated with selective iNOS inhibition re-
sults in a decrease in lung and liver injury. Taken together,
the findings suggest that constitutive NOS is protective,
but that the quantities of NO generated by iNOS cause in-
jury. Our results suggest that organ damage in hemorrhagic
shock is due, at least in part, to the proinflammatory action
of NO. NO in combination with superoxide forms peroxy-
nitrite, which could exert direct tissue toxicity. The results
in hemorrhagic shock are contrasted by the observations in
endotoxemia where the role of iNOS is less clear. iNOS
Figure 10. NF-kB and Stat3 activation in the liver of wild-type (WT)
and iNOS knockout (KO) mice subjected to hemorrhagic shock. EMSA
was performed using radiolabeled NF-kB duplex oligonucleotide (A) or
radiolabeled hSIE (C) and 20 mg of protein extracts of shock and sham
wild-type or knockout mice. The position of NF-kB and the SIF-A, -B,
and -C complexes are indicated on the left. In B and D, the radioactive
signal was quantitated by PhosphorImager analysis and plotted. The values
shown are mean 6 SEM. Black bars, wild-type mice (n 5 5); gray bars,
knockout mice (n 5 5). In shocked wild-type mice, the activation of
NF-kB and the activation of Stat3 homodimer (SIFA) were increased sig-
nificantly compared to sham wild-type mice (P <0.01). In shocked
knockout mice NF-kB activation was reduced 62% (P 5 0.02) and acti-
vation of Stat3 homodimer (SIFA) was reduced 54% (P 5 0.01) com-
pared to shocked wild-type mice.
Figure 11. Hepatic injury in wild-type (WT) and iNOS knockout (KO)
mice subjected to hemorrhagic shock. The release of the hepatocellular
enzyme ALT into plasma was used as an index of hepatic injury. ALT re-
lease (IU/liter) from shock and sham wild-type or knockout mice was
measured using an autoanalyzer (RA 500; Technitron) and plotted. Val-
ues shown are mean 6 SEM. Black bars, wild-type (WT) animals (n 5 5);
gray bars, knockout (KO) animals (n 5 5). In shocked wild-type mice,
ALT levels demonstrated a 40-fold increase compared to sham wild-type
mice (P ,0.01). In shocked knockout mice, ALT levels were reduced
80% (P ,0.01) compared to shocked wild-type mice.927 Hierholzer et al.
knockout mice treated with high-dose endotoxin showed
no difference in end organ damage when compared with
their wild-type counterparts (11). More recently, we have
shown that iNOS inhibition during endotoxemia increases
apoptosis in the liver without necrosis (38). Difference be-
tween endotoxemia and hemorrhagic shock may be related
to the higher levels of superoxide production and greater
oxidant stress in the latter.
Approaches to remove NO in hemorrhagic shock could
have therapeutic benefit. Patients suffering severe or sus-
tained hemorrhagic shock after trauma or due to other
causes of bleeding (e.g., ruptured aortic aneurysm) can de-
velop organ injury and dysfunction. Our results indicate
that selective inhibition of iNOS may be a reasonable ap-
proach. Alternatively, NO scavengers may also preserve ad-
equate levels of NO needed to maintain perfusion while
removing the excess NO which promotes inflammation
and tissue injury.
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